Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides

被引:51
作者
Mo, AXY [1 ]
van Lelyveld, SFL [1 ]
Craiu, A [1 ]
Rock, KL [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
关键词
D O I
10.4049/jimmunol.164.8.4003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The proteasome has been shown to make the proper C-terminal cleavage for the generation of several immunodominant class I-presented peptides whereas aminopeptidases generate their proper N termini, In this study, we show that these two distinct proteolytic processes are also involved in generating a subdominant OVA peptide KVVRFDKL (K-L), Moreover, proteasome inhibitors did not enhance the presentation of any K-L construct, suggesting that destruction of this peptide by proteasomes, if any, does not limit its presentation. We have further examined in intact cells the influence of residues flanking this epitope on these proteolytic processes. When the N-terminal flanking residues of K-L are fused to an immunodominant OVA peptide SIINFEKL (S-L), the presentation of S-L is reduced as compared with a construct with its natural flanking sequence and was not inhibited (or enhanced) by proteasome inhibitors. Similarly, a reduction in presentation was observed when the C-terminal flanking residues of the subdominant epitope were attached to S-L, A detailed analysis revealed that the Pro at the P1' position of K-L was responsible for this reduction, and presentation of these C-terminally extended constructs was sensitive to proteasome inhibitor. The study suggests that both the N- and C-terminal hanks of the subdominant peptide are suboptimal for Ag presentation Moreover, three of four C-terminal residues that flank other subdominant or cryptic epitopes in OVA reduced the presentation of S-L, Therefore, the residues that flank the C termini of several subdominant and cryptic epitopes are often suboptimal for cleavage and may contribute to the phenomenon of immunodominance.
引用
收藏
页码:4003 / 4010
页数:8
相关论文
共 46 条
[1]   The proteasome:: Paradigm of a self-compartmentalizing protease [J].
Baumeister, W ;
Walz, J ;
Zühl, F ;
Seemuller, E .
CELL, 1998, 92 (03) :367-380
[2]   Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase [J].
Beninga, J ;
Rock, KL ;
Goldberg, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (30) :18734-18742
[3]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[4]   INTERFERON-GAMMA STIMULATION MODULATES THE PROTEOLYTIC ACTIVITY AND CLEAVAGE SITE PREFERENCE OF 20S MOUSE PROTEASOMES [J].
BOES, B ;
HENGEL, H ;
RUPPERT, T ;
MULTHAUP, G ;
KOSZINOWSKI, UH ;
KLOETZEL, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :901-909
[5]   Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes [J].
Bogyo, M ;
Shin, S ;
McMaster, JS ;
Ploegh, HL .
CHEMISTRY & BIOLOGY, 1998, 5 (06) :307-320
[6]   DETERMINANT SELECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED ANTIGENIC PEPTIDES IS EXPLAINED BY CLASS I-PEPTIDE AFFINITY AND IS STRONGLY INFLUENCED BY NONDOMINANT ANCHOR RESIDUES [J].
CHEN, WS ;
KHILKO, S ;
FECONDO, J ;
MARGULIES, DH ;
MCCLUSKEY, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1471-1483
[7]   Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[8]   Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide [J].
Craiu, A ;
Akoplan, T ;
Goldberg, A ;
Rock, KL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10850-10855
[9]   Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation [J].
Craiu, A ;
Gaczynska, M ;
Akopian, T ;
Gramm, CF ;
Fenteany, G ;
Goldberg, AL ;
Rock, KL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) :13437-13445
[10]  
DEL VM, 1991, CELL, V66, P1145